glp 1 agonist lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating In the same week that

Improved kidney function: Recent developments in the management of T2D have identified the use of GLP-1s to reduce the progression of kidney disease in individuals with diabetes

We put our clients first in every aspect of our representation by seeking to understand their lived experiences and crafting a legal strategy that can lead to compensation

This contribution is part of the broader research project RESISTING - Reconnecting Social Innovation with Institutions in Urban Planning, funded under the National Research Program of National Interest (PRIN NRRP 2022), within Italys National Recovery and Resilience Plan

, L-

Clinical, Cosmetic and Investigational Dermatology, 267